F Swan

56 papers receiving 3.1k citations

F Swan's Hit Papers

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP) 1988 · 500 citations
5000+12+25Years since publication100200300400500

Peers

F Swan
Comparison fields: 5 of 80
  • Pathology and Forensic Medicine 2.3k
  • Genetics 844
  • Oncology 1.3k
  • Neurology 611
  • Hematology 239
Replace Frederick Hagemeister with:
Frederick Hagemeister United States
Andreas Lohri Switzerland
Catherine Sebban France
B Coiffier France
William S. Velasquez United States
Y Bastion France
José Thomas Belgium
Christophe Fermé France
Andreas Josting Germany
Max Wolf Australia
F Swan relative to Frederick Hagemeister United States Frederick Hagemeister's profile →
Citations per field
00.5×1.5×
Frederick Hagemeister · 1×
Citations per year

Countries citing papers authored by F Swan

Since Specialization
Citations

This map shows the geographic impact of F Swan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Swan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Swan more than expected).

Fields of papers citing papers by F Swan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Swan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Swan. The network helps show where F Swan may publish in the future.

Co-authors

The 25 scholars most cited alongside F Swan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F Swan Line = papers co-authored together F Swan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)
Hit paper breakdown →
1988500
2 1994358
3 1996226
4 1992182
5 1989134
6 1992101
7 198996
8 199589
9 199186
10 199285
11 199481
12 199981
13 199479
14 199978
15 199166
16 199366
17 198963
18
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
198860
19 199454
20 199052

About F Swan

F Swan is a scholar working on Pathology and Forensic Medicine, Oncology, Neurology, Genetics and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (40 papers), CNS Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Lung Cancer Treatments and Mutations (7 papers), Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.3k citations), Genetics (844 citations), Oncology (1.3k citations), Neurology (611 citations) and Hematology (239 citations). F Swan has collaborated with scholars based in United States, Belgium and Pakistan. Frequent co-authors include Peter McLaughlin, Fernando Cabanillas, Fredrick B. Hagemeister, Maria Alma Rodriguez, Jorge Romaguera, William S. Velasquez, J R Redman, JR Redman, Sundar Jagannath and FB Hagemeister. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Blood, American Journal of Clinical Pathology and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact